Skip to main content

Advertisement

Table 2 Cell death induced by rituximab and obinutuzumab in MCL

From: Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

  Rituximab Obinutuzumab Rituximab vs obinutuzumab
Cell death (%) p-value Cell death (%) p-value p-value
JeKo-1 1.31. ± 0.26 0.024* 3.00 ± 1.02 0.012* 0.030*
REC-1 2.15 ± 0.85 0.029* 2.64 ± 1.31 0.038* 0.493
  1. * p < 0.05